Search

everythinglearnresearchcommunity

for

Search:↓

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

Tsc2-deficient stem cells can help understand and treat TSC-related tumors.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

Keratin-associated proteins are part of the developing hair fiber cuticle.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

The new treatment improved keratosis pilaris symptoms and mood in 28 days.

The 10% hibiscus leaf extract hair tonic promotes better hair growth than 2% minoxidil but causes eye irritation.

Golden takin's hair structure is adapted to maintain body temperature in harsh winters.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

STITCH improves suture accuracy and efficiency, especially with human help.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Consider TFI in facial hypopigmentation diagnoses and confirm with a biopsy.

The study found a specific peptide that helps detect TGase 3 activity in skin and hair follicles.

Matriptase is crucial for skin, hair, and immune cell health, and its imbalance can lead to cancer.

STAR particles are safe, comfortable, and effective for enhancing drug delivery through the skin.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Inward rectifier potassium channels are important in many body functions and diseases, and could be potential drug targets.

Raspberry ketone may help grow hair and improve skin elasticity.

Trichoscopy is a key method for dermatologists to quickly and effectively diagnose hair and scalp conditions.

MMP-2 and MMP-9 help hair grow, while their inhibitors peak when hair growth slows.

JAK inhibitors show promise for treating various skin diseases.

New findings on hair keratin, wound healing, and skin blistering were presented.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.